Ketamine is genuinely dangerous in some contexts and remarkably safe in others, and the difference comes down to dose, frequency, and supervision. A single low-dose infusion in a clinical setting carries mostly transient side effects like a temporary rise in blood pressure and brief dissociation. Chronic heavy recreational use, by contrast, can destroy the bladder lining, damage bile ducts, erode white matter in the brain, and lead to psychological dependence. The gap between those two scenarios is enormous, yet both involve the same molecule.
Why Dose and Setting Change Everything
Ketamine was introduced into clinical practice in the 1960s as an anesthetic and has been used continuously in hospitals and field medicine ever since, partly because it does not suppress breathing the way many other anesthetics do.1PubMed Central. Ketamine: 50 Years of Modulating the Mind More recently, it has been recognized as a fast-acting antidepressant, particularly for people whose depression has not responded to standard medications.2Neuropsychopharmacology. Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms In that psychiatric context, doses are far below anesthetic levels, sessions happen perhaps once or twice a week for a few weeks, and a clinician monitors the patient throughout.
Recreational users tend to take the drug much more frequently and in larger amounts. A systematic review comparing recreational and clinical exposure found that heavy recreational users accumulate more than 90 times the cumulative ketamine exposure of patients treated in clinical settings. That enormous difference in total drug exposure helps explain why serious adverse events in clinical use are mostly mild and reversible, while chronic recreational users face organ damage, dependence, and cognitive decline.3PubMed. Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study This does not mean clinical use is risk-free, but the risk profile is in a different category altogether.
Acute Side Effects You Can Expect
Even at the low, sub-anesthetic doses used for depression treatment, ketamine reliably produces a handful of short-term effects. The most common are dissociation (a feeling of being detached from your body or surroundings), nausea, dizziness, headache, and a transient increase in blood pressure. In at-home sublingual ketamine programs, these effects were self-limited and resolved without medical intervention.4Frontiers in Psychiatry. Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use One large real-world dataset from a telehealth ketamine program found that adverse events showed up in roughly 3 to 5 percent of participants and were predominantly neurological or psychiatric in nature, meaning things like excessive dissociation or anxiety rather than organ problems.5PubMed Central. At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data
The blood pressure spike deserves special attention. In a study of over 2,300 clinical ketamine infusions across 138 patients, systolic blood pressure rose by an average of about 16 mmHg and diastolic by about 11 mmHg, peaking around 40 minutes into the infusion. Roughly one in eight patients experienced at least one episode of severe hypertension, and this was more common during the first few infusions and in older patients or those with a history of high blood pressure.6General Hospital Psychiatry. Blood pressure changes during ketamine infusion for the treatment of depression A separate study reported smaller average increases of about 7 mmHg systolic and 6 mmHg diastolic, but confirmed the same pattern: older patients and those already hypertensive saw bigger spikes.7PubMed. Cardiovascular effects of repeated subanaesthetic ketamine infusion in depression For most healthy people this is manageable, but if you have poorly controlled blood pressure or cardiovascular disease, the spike is a real concern that your provider should monitor closely.
What Heavy Use Does to the Bladder
The most devastating long-term consequence of chronic ketamine use is what happens to the urinary tract. The condition, often called ketamine-induced cystitis, typically starts with urinary frequency and urgency that get progressively worse. Over time, the bladder wall becomes inflamed and fibrotic, bladder capacity shrinks, and the pain becomes severe. In advanced cases, the damage extends beyond the bladder to cause narrowing of the ureters, reflux of urine back toward the kidneys, and eventually kidney failure.8PubMed Central. Pathophysiology, clinical presentation, and management of ketamine-induced cystitis
The exact mechanism is not fully understood, but the leading theory is that ketamine and its breakdown products in urine directly damage the bladder’s protective lining, triggering inflammation, oxidative stress, and eventually scarring.9PubMed Central. Ketamine-Induced Cystitis: A Comprehensive Review of the Urologic Effects of This Psychoactive Drug What makes this especially alarming is that in advanced stages, the damage can be irreversible. Stopping ketamine use early enough allows some recovery, but once the bladder has contracted and scarred, the only options may be radical reconstructive surgery.10PubMed Central. Ketamine bladder syndrome: an important differential diagnosis when assessing a patient with persistent lower urinary tract symptoms This is not a theoretical risk reserved for extreme users. Clinicians who treat young recreational users report seeing bladder damage surprisingly often, and it tends to progress silently before people seek help.
Liver and Bile Duct Damage
The bladder gets most of the attention, but the liver and biliary system are also vulnerable. A cross-sectional survey of nearly 300 chronic ketamine users with urinary tract problems found liver injury in about one in ten of them, and all of those cases were classified as cholestatic, meaning the damage involved impaired bile flow rather than direct liver cell death. Biopsies showed bile duct injury, and in some patients, bridging fibrosis, a sign that the liver is scarring.11PubMed Central. Hepatobiliary Complications Associated With Ketamine Use: Clinical Insights and Future Directions
A separate imaging study of 26 chronic users found that about 70 percent had abnormal widening of the common bile duct without any physical blockage, and the degree of dilation correlated with how long they had been using ketamine.12PubMed. Ketamine-related cholangiopathy: a retrospective study on clinical and imaging findings This pattern, sometimes called ketamine-related cholangiopathy, can mimic other biliary diseases on imaging and may be missed if the clinician does not know to ask about ketamine use. The take-home point is that chronic heavy use can quietly damage the biliary system well before symptoms become obvious.
Effects on Memory and Brain Structure
Chronic ketamine use takes a measurable toll on the brain. Heavy users show deficits in spatial working memory compared to non-users, struggling more with tasks that require holding and manipulating spatial information.13Frontiers in Psychiatry. Long-Term Heavy Ketamine Use is Associated with Spatial Memory Impairment and Altered Hippocampal Activation Animal research helps explain why: in mice, 28 days of daily ketamine exposure reduced the levels of key proteins involved in synaptic signaling, decreased the density of dendritic spines (the small protrusions where neurons receive signals), and impaired learning and memory. These changes persisted for at least four weeks after the last dose, suggesting the damage is not quickly reversible.14PubMed. Chronic administration of ketamine induces cognitive deterioration by restraining synaptic signaling
Brain imaging studies tell a similar story. In chronic human ketamine users, researchers have found reduced integrity of white matter, the insulated wiring that connects brain regions. The disruption was widespread but particularly affected pathways between deeper brain structures and the prefrontal cortex, and it partly predicted how intense users’ dissociative experiences were.15PubMed Central. Abnormalities in white matter microstructure associated with chronic ketamine use An animal study in adolescent monkeys confirmed these findings: chronic ketamine caused significant white-matter abnormalities across multiple brain regions, including areas involved in language processing, motor control, and sensory relay.16Frontiers in Neuroscience. Chronic Ketamine Exposure Causes White Matter Microstructural Abnormalities in Adolescent Cynomolgus Monkeys Whether these changes fully reverse with abstinence in humans is an open question, but the evidence so far suggests that at minimum, recovery takes considerable time.
Psychotic-Like Experiences
Ketamine’s mechanism of action, blocking certain receptors for the brain chemical glutamate, overlaps with some of the neurochemical abnormalities seen in schizophrenia. This is not just a theoretical connection. A study of young recreational ketamine users found a clear positive correlation between how frequently someone used ketamine and how many psychotic-like experiences they reported, including things like paranoid thoughts, perceptual disturbances, and disorganized thinking. Other substances the participants used, including cannabis, MDMA, and alcohol, did not show the same relationship.17PubMed. Psychotic-Like Experiences in Young Recreational Users of Ketamine: A Case Study For most clinical patients receiving a handful of supervised low-dose sessions, this is unlikely to be a problem. But for people who use ketamine frequently, especially those with a personal or family history of psychotic disorders, the risk of triggering or worsening psychotic symptoms is real.
Dependence, Tolerance, and Withdrawal
Ketamine can be addictive, though the pattern looks different from classic physical addictions like opioid or alcohol dependence. Users who become dependent tend to develop a strong craving and rapidly escalating tolerance, meaning they need larger and larger doses to get the same effect. The pattern resembles stimulant dependence more than opioid dependence.18PubMed. The nonmedical use of ketamine, part two: A review of problem use and dependence A comprehensive review confirmed that long-term recreational use is associated with psychological dependence and tolerance development.19PubMed Central. The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use
Withdrawal, while not as physically intense as alcohol or benzodiazepine withdrawal, is more than purely psychological. Documented symptoms include craving, low mood, shaking, sweating, palpitations, insomnia, nightmares, anxiety, and in some cases hallucinations and delusions. The acute phase typically begins within 24 hours of stopping and peaks over the first three days. Symptoms generally start to taper after about two weeks, with most people stabilizing around that point.20Brain Communications. Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development Importantly, dependence has not been reported in patients receiving ketamine in clinical treatment settings, again highlighting the gulf between supervised medical use and self-directed recreational use.3PubMed. Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study
Overdose and Death
Ketamine’s wide safety margin as an anesthetic, meaning the distance between an effective dose and a lethal dose, is one of the reasons it became a staple in emergency and battlefield medicine. Fatal overdoses from ketamine alone are rare, but they do happen. A systematic review identified 138 ketamine-related deaths and 312 overdose cases across the literature. Poly-substance use was mentioned in more than half the reports, meaning other drugs were often involved. Ketamine was the primary substance in about 89 percent of the deaths and 79 percent of the overdose cases. Critically, no cases of overdose or death were found in patients receiving ketamine as an antidepressant in a therapeutic setting, and most overdose cases left no lasting harm.21PubMed. Overdoses and deaths related to the use of ketamine and its analogues: a systematic review
The biggest acute danger during ketamine intoxication is not respiratory failure, as with opioids, but rather the loss of protective reflexes. A deeply intoxicated person can vomit and aspirate, fall and injure themselves, or wander into dangerous situations while dissociated. Mixing ketamine with depressants like alcohol or benzodiazepines amplifies these risks considerably.
Driving and Psychomotor Impairment
Even at sub-anesthetic, analgesic-range doses, ketamine significantly impairs the ability to operate a vehicle. In a simulator study, participants given escalating low-dose intravenous ketamine showed worsening lane-keeping ability at every dose level. At the highest dose tested, the degree of impairment was considered incompatible with safe driving. Reassuringly, simulated driving performance returned to baseline levels two hours after the infusion stopped.22Progress in Neuro-Psychopharmacology and Biological Psychiatry. The acute and residual effects of escalating, analgesic-range doses of ketamine on driving performance: A simulator study Another study found that psychomotor impairment becomes significant once plasma concentrations rise above a certain threshold, and effects can last longer than an hour even after a single oral dose.23Forensic Science International. Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability
Research also shows that ketamine increases sleepiness and decreases people’s confidence in their own driving abilities, which at least suggests some self-awareness of impairment. But the acute effects on cognition and motor function are distinct from the subjective feeling of sedation, meaning someone could feel alert enough to drive while still being objectively impaired.24PubMed Central. Ketamine Evolving Clinical Roles and Potential Effects with Cognitive, Motor and Driving Ability Anyone receiving ketamine in any setting should treat it the way they would treat surgical sedation and not drive for the rest of the day.
Risks to Developing Brains
One area where the evidence is genuinely concerning involves exposure during early brain development. Animal studies, including work in rodents and primates, have consistently shown that ketamine can trigger widespread death of neurons in the developing brain through a process called apoptosis, or programmed cell death. This cell loss can alter brain structure and produce lasting behavioral changes evident into adulthood.25PubMed Central. Ketamine-induced neurotoxicity in neurodevelopment: A synopsis of main pathways based on recent in vivo experimental findings Additional research suggests that ketamine can also disrupt the process by which neural stem cells generate new neurons, adding another mechanism of potential harm to the immature brain.26Toxicology Letters. Developmental neurotoxicity of ketamine in pediatric clinical use
This matters for two populations. First, ketamine is sometimes used as a pediatric anesthetic, and the widespread use and misuse of the drug in infants and pregnant women has raised concerns about neurotoxicity to the immature brain.27PubMed Central. Effects of Perinatal Exposure to Ketamine on the Developing Brain Second, pregnant women who use ketamine recreationally may be exposing developing fetuses during critical windows of brain formation. Translating animal findings to humans is always uncertain, especially because the doses and durations in animal studies are often much higher than typical clinical use. But the consistency of the animal data across species has been enough for researchers to flag this as a genuine concern rather than a theoretical one.
Illicit Ketamine and Contaminant Risks
People using ketamine outside a medical setting face an additional layer of risk that has nothing to do with ketamine itself: they do not know exactly what they are taking. Street drugs are routinely adulterated with bulking agents and other active substances. Common adulterants across illicit drugs include caffeine, local anesthetics, and sugars, which are added to increase bulk. While many of these are relatively harmless at low doses, injectable preparations carry particular risks from bacterial contamination. In the current drug supply, the rise of potent synthetic opioids means that any illicit powder could potentially contain traces of fentanyl or its analogues, a contamination scenario that has turned otherwise survivable overdoses into fatal ones across many drug categories.
At-Home Ketamine Programs and Telehealth
The rapid expansion of telehealth ketamine prescribing for depression and anxiety has created a new middle ground between fully supervised clinic infusions and unsupervised recreational use. In these programs, patients typically receive sublingual tablets at home after being screened and monitored remotely by a clinician. The available data on these programs is reassuring but limited. One large effectiveness trial of at-home sublingual ketamine found that patient screening and remote monitoring maintained low levels of adverse events, with only a handful of participants discontinuing treatment due to side effects or clinician concerns.28Journal of Affective Disorders. At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial
The concern with this model is not that any one at-home session is dangerous, but rather what happens at the margins. Without in-person monitoring, blood pressure spikes go unmeasured. Without direct observation, there is less oversight of whether patients are taking the prescribed dose, storing the medication securely, or developing a pattern of escalating use. These programs are new enough that long-term safety data simply does not exist yet, and the safeguards built into them vary significantly from company to company. For someone considering this route, asking about the provider’s screening protocols, monitoring procedures, and policies for escalating care is worth the awkwardness.
How Recreational and Clinical Risk Profiles Diverge
The recurring theme across every category of harm, bladder damage, liver injury, cognitive decline, dependence, is that cumulative exposure is the critical variable. Clinical patients receiving a course of six infusions over a few weeks are operating in a completely different pharmacological universe from someone snorting ketamine several times a week for months or years. The systematic review that quantified this gap found that heavy recreational users accumulate more than 90 times the ketamine exposure of clinical patients, and that serious adverse events in the clinical context were mostly mild and reversible. Dependence was not reported in clinical patients at all.3PubMed. Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study
This should not breed complacency about medical ketamine. Clinical use is still relatively new in psychiatry, long-term follow-up data on repeated courses of treatment is thin, and the field has not settled on clear limits for how many lifetime sessions are safe. It does mean that reading about bladder destruction and bile duct damage and concluding that a supervised infusion for depression carries the same risks would be a significant misreading of the evidence. The dangers are real, but they scale with exposure in a way that matters enormously for how you think about your own situation.